Health & Fitness
Health and Fitness
Health and Fitness 
Fri, May 22, 2009
Thu, May 21, 2009
Wed, May 20, 2009
Eurand N.V.: Eurand to Present at UBS Global Specialty Pharmaceuticals Conference in London
PHILADELPHIA, PA--(Marketwire - May 20, 2009) - Eurand N.V. (
Event: UBS Global Specialty Pharmaceuticals Conference Date: Tuesday, June 2, 2009 Time: 11:00 a.m. BST (6:00 a.m. ET) Location: The Waldorf Hilton Hotel London, U.K.
An audio webcast of the Company's presentation will be available by accessing the investor relations section of Eurand's web site at [ www.eurand.com ] and will be available via replay until July 2, 2009.
About Eurand
Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had five products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. The Company's technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking orally disintegrating tablet (ODT) formulations, and drug conjugation.
Eurand is a global company with facilities in the U.S. and Europe. For more information, visit [ www.eurand.com ].